Main Sector of relevance\IRC classification 11. Sciences (Chemistry, Physics etc)

11.3 To develop and bring under production low frequency therapy device.

Developers’ contact information

State Scientific Institution “The Institute of Physiology of the National Academy of Sciences of Belarus”
28 Akademicheskaya Str., 220072 Minsk
V.S. Levkovets, Candidate of Science (Biology)
tel./fax: +375 (17) 284-16-31

Summary

New prototype model for low frequency ultrasonic therapy will be made, and prototype model for inflammatory process treatment were tested in laboratory as a result of project implementation.

Description

Four prototype models for low frequency therapy ANUZT 1-100 were produced. Compliance of prototype models and project documentation and design specification were tested in laboratory.

Technology type

• Other:
  Device and its medical use

Technical advantages and economic benefits

Technical characteristics of physiotherapeutic device are as per GOST (Standarts) of the Republic of Belarus. Production technology is characterized by economical advantages in comparison with production of analogous devices

Technology differentiation and uniqueness

Device for low frequency therapy is used for treatment of socially important diseases

Context in which technology was identified

—

Technological keywords

—

Development Stage

• Prototype
• Other:
  Results of experimental studies are available. As a result of the studies was determined that the most favorable reparative conditions for inflammatory response reduction are created during exposure with low frequency ultrasound at 22 kHz within 5 minutes accompanied by normalization of hematologic indexes (blood sedimentation rate, white blood count, leukogram), authentic reduction of serum concentration of sulphurglicoids and alkaline phosphatise in comparison with control animal group. Use of the same frequency within 10 minutes has less frank anti-inflammatory effect and characterised by more inert regenerative process and less prominent positive change of peripheral blood. Maximum antiedematous effect of low frequency ultrasound to the end the treatment was at 22 kHz within 5 minutes which induced statistically significant decrease of puffiness by 88.1%.

Intellectual property rights

• Other:
  Application for a patent is being prepared.

Range of applications

Medicine

Classifier Used at the EU Innovation Relay Centres

• Sciences (Chemistry, Physics etc)

Preferable Regions

• Europe
• Africa

Practical experience

—

Environmental impact

None

Type of collaboration sought

• R&D contract

Terms and restrictions

Technology transfer only under approval of product engineers

Available technical assistance

• Documentation